Key statistics
As of last trade, Elanco Animal Health Inc (ELAN:NYQ) traded at 13.35, 17.11% above the 52 week low of 11.40 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.37 |
---|---|
High | 13.46 |
Low | 13.15 |
Bid | 13.35 |
Offer | 13.36 |
Previous close | 13.40 |
Average volume | 3.86m |
---|---|
Shares outstanding | 494.35m |
Free float | 491.10m |
P/E (TTM) | 32.79 |
Market cap | 6.62bn USD |
EPS (TTM) | 0.4087 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 18:10 GMT.
More ▼
- Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain
- Elanco Strengthens Board of Directors with Addition of Stacey Ma
- Elanco Animal Health Reports Third Quarter 2024 Results
- Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement
- Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose
- Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
- Elanco Provides Update on Contract Manufacturing Partner
- Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼